Astria Therapeutics, Inc. (ATXS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 253.55M | 268.59M | 302.97M | 334.64M | 351.86M | 357.89M | 374.52M | 250.94M | 191.47M | 204.41M | 215.44M | 227.69M |
| Cash & Short-Term Investments | 227.72M | 259.18M | 295.06M | 328.13M | 344.28M | 354.7M | 369.91M | 246.53M | 188.81M | 202.96M | 213.33M | 226.44M |
| Cash Only | 96.28M | 76.32M | 54.38M | 59.82M | 80.9M | 87.21M | 172.01M | 175.53M | 119.81M | 133.96M | 202.3M | 20.52M |
| Short-Term Investments | 131.44M | 182.86M | 240.68M | 268.31M | 263.38M | 267.49M | 197.9M | 71M | 69M | 69M | 11.03M | 205.91M |
| Accounts Receivable | 17.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 8.91K | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 8.58M | 0 | 7.9M | 6.51M | 7.58M | 3.19M | 163K | 4.41M | 2.66M | 1.46M | 2.12M | 1.25M |
| Total Non-Current Assets | 18.32M | 13.34M | 7.42M | 7.72M | 9.78M | 10.1M | 4.29M | 3.72M | 2.4M | 2.64M | 2.79M | 2.94M |
| Property, Plant & Equipment | 4.25M | 4.55M | 4.83M | 5.11M | 5.39M | 5.71M | 210K | 363K | 514K | 661K | 806K | 948K |
| Fixed Asset Turnover | 0.17x | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 14.07M | 8.79M | 2.59M | 2.61M | 4.39M | 4.38M | 4.08M | 3.36M | 1.88M | 1.98M | 1.99M | 2M |
| Total Assets | 271.87M | 281.92M | 310.39M | 342.36M | 361.64M | 367.99M | 378.81M | 254.67M | 193.86M | 207.05M | 218.24M | 230.63M |
| Asset Turnover | 0.00x | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -24.82% | -23.39% | -18.06% | 34.44% | 86.55% | 77.73% | 73.57% | 10.42% | 61.8% | 96.64% | 90.35% | 80.87% |
| Total Current Liabilities | 23.52M | 18.04M | 17.43M | 19.13M | 15.72M | 16.37M | 11.07M | 11.55M | 9.38M | 6.6M | 6.67M | 9.06M |
| Accounts Payable | 1.14M | 738K | 3.69M | 4.32M | 1.28M | 2.34M | 862K | 1.51M | 1.14M | 829K | 930K | 788K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 4.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.85M | 0 | 1.94M | 0 | 0 | 10.24M | 0 | 4.05M | 2.67M | 1.74M | 974K | 3.37M |
| Current Ratio | 10.78x | 14.89x | 17.39x | 17.49x | 22.38x | 21.87x | 33.83x | 21.73x | 20.41x | 30.98x | 32.29x | 25.13x |
| Quick Ratio | 10.78x | 14.89x | 17.39x | 17.49x | 22.38x | 21.87x | 33.83x | 21.73x | 20.41x | 30.98x | 32.29x | 25.13x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 15.1M | 3.37M | 3.67M | 3.97M | 4.26M | 4.54M | 0 | 0 | 0 | 53K | 207K | 357K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 3.06M | 3.37M | 3.67M | 3.97M | 4.26M | 4.54M | 0 | 0 | 0 | 53K | 207K | 357K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 38.61M | 21.41M | 21.1M | 23.1M | 19.98M | 20.91M | 11.07M | 11.55M | 9.38M | 6.65M | 6.88M | 9.42M |
| Total Debt | 4.46M | 4.77M | 5.06M | 5.35M | 5.64M | 5.79M | 168K | 329K | 488K | 643K | 794K | 939K |
| Net Debt | -91.82M | -71.55M | -49.32M | -54.47M | -75.26M | -81.42M | -171.84M | -175.2M | -119.32M | -133.31M | -201.51M | -19.59M |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 233.25M | 260.51M | 289.29M | 319.26M | 341.65M | 347.08M | 367.74M | 243.12M | 184.48M | 200.4M | 211.36M | 221.22M |
| Equity Growth % | -31.73% | -24.94% | -21.33% | 31.32% | 85.2% | 73.19% | 73.99% | 9.9% | 63.44% | 101.57% | 92.7% | 80.86% |
| Book Value per Share | 4.02 | 4.49 | 4.99 | 5.66 | 6.05 | 6.14 | 7.03 | 6.66 | 6.58 | 7.15 | 7.56 | 12.01 |
| Total Shareholders' Equity | 233.25M | 260.51M | 289.29M | 319.26M | 341.65M | 347.08M | 367.74M | 243.12M | 184.48M | 200.4M | 211.36M | 221.22M |
| Common Stock | 57K | 57K | 57K | 57K | 57K | 55K | 55K | 41K | 28K | 28K | 28K | 28K |
| Retained Earnings | -773.2M | -741.55M | -708.5M | -674.79M | -649.17M | -624.63M | -600.46M | -580.53M | -549.12M | -531.4M | -518.83M | -507.64M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 56K | -16K | 60K | 163K | 331K | -45K | -14K | 0 | 0 | 0 | -4K | -79K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |